Chronic, but not acute, clomipramine or fluoxetine treatment reduces the spontaneous firing rate in the mesoaccumbens neurons of the rat

Neuropsychobiology

Volumn 48, Issue 3, 2003, Pages 116-123

  Rodríguez Landa, Juan Francisco ^a   Contreras, Carlos M ^a   Gutiérrez García, Ana G ^a   Bernal Morales, Blandina ^a  

^a NONE

Author keywords

Antidepressants; Clomipramine; Dopamine; Fluoxetine; Mesolimbic system; Nucleus accumbens; Ventral tegmental area

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; FLUOXETINE; SODIUM CHLORIDE;

ACTION POTENTIAL; ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DRUG MECHANISM; HYPOTHESIS; MALE; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RAT STRAIN; RECORDING; VENTRAL TEGMENTUM;

ACTION POTENTIALS; ANIMALS; ANTIDEPRESSIVE AGENTS; CLOMIPRAMINE; DRUG ADMINISTRATION SCHEDULE; FLUOXETINE; MALE; NEURONS; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; TIME FACTORS;

EID: 0242362715     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073627     Document Type: Article

References (61)

1. Willner P: The mesolimbic dopamine system as a target for rapid antidepressant action. Int Clin Psychopharmacol 1997;12:7-14.
2. Bonhomme N, Esposito E: Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: A review. J Clin Psychopharmacol 1998;18:447-454.
3. Di Chiara G: Psychobiology of the role of dopamine in drug-abuse and addiction. Neurosci Res Commun 1995;17:133-143.
4. Wilson C, Nomikos GG, Collu M, Fibiger HC: Dopamineric correlates of motivated behavior: Importance of drive. J Neurosci 1995;15:5169-5178.
5. Garris PA, Kilpatrick M, Bunin MA, Michael D, Walker QD, Wightman RM: Dissociation of dopamine release in the NAcc from intracranial self-stimulation. Nature 1999;398:67-69.
6. Cervo L, Samanin R: Evidence that dopamine mechanisms in the NAcc are selectively involved in the effect of desipramine in the forced swimming test. Neuropharmacology 1987;26:1469-1472.
7. Ichikawa J, Meltzer HY: Effect of antidepressants on striatal and accumbens extracellular dopamine levels. Eur J Pharmacol 1995;281:255-261.
8. De Montis GM, Devoto P, Gessa GL, Meloni D, Porcella A, Saba P, Serra G, Tagliamonte A: Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. Eur J Pharmacol 1990;180:31-35.
9. Scavone C, Aizenstein ML, Da Silva Planeta C, De Lucia R: Long-term effects of imipramine on striatal dopamine autoreceptor function: Involvement of both noradrenergic and serotonergic systems. Gen Pharmacol 1992;23:397-401.
10. Brown AS, Gershon S: Dopamine and depression. J Neural Transmission 1993;91:75-109.
11. Clark RN, Ashby CR Jr, Dewey SL, Ramachandran PV, Strecker RE: Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat. Synapse 1996;23:125-131.
12. Spyraki C, Fibiger C: Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur J Pharmacol 1981;74:195-206.
13. 2 dopaminergic receptors induced by chronic treatment with imipramine. Neurosci Lett 1988;33:180-181.
14. 1 receptor in the behavioral supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Brain Res 1990;527:234-243.
15. 2 receptors in chronic fluoxetine-treated rats. Eur J Pharmacol 1997;322:123-127.
16. Willner P, Montgomery A: Behavioural changes during withdrawal from the tricyclic antidepressant desmethylimipramine (DMI): Interactions with amphetamine. Psychopharmacology 1981;75:54-59.
17. Maj J, Wedzony K: Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the NAcc. J Pharm Pharmacol 1985;37:362-364.
18. Maj J, Wedzony K, Klimek V: Desipramine given repeatedly enhances behavioural effects of dopamine and D-amphetamine injected into the NAcc. Eur J Pharmacol 1987;140:179-185.
19. 2 receptors in the rat brain. Eur J Pharmacol 1996;304:49-54.
20. 3H]SCH 23390 binding and DA-sensitive adenylate cyclase in the limbic system. Eur J Pharmacol 1989;167:299-303.
21. 2 receptors. J Pharma Pharmacol 1989;41:555-558.
22. 2 dopamine receptors in the rat brain. J Neural Transm 1997;104:515-524.
23. 2 receptor expression and dopamine release in the NAcc of the rat. Psychopharmacology (Berl) 1998;140:470-477.
24. 3 receptors in the rat brain differentiated by agonist and antagonist binding: An autoradiographic analysis. Naunyn Schmiedeberg's Arch Pharmacol 1999;359:178-186.
25. Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597-606.
26. Mogenson GJ, Yang CR, Yim CY: Influence of dopamine on limbic inputs to the nucleus accumbens. Ann NY Acad Sci 1988;537:86-100.
27. Salomone JD, Cousins MS, McCullough LD, Carriero DL, Berkowitz RL: NAcc dopamine release increases during instrumental lever pressing for food but not free food consumption. Pharmacol Biochem Behav 1992;49:25-31.
28. Willner P, Muscat R, Papp M: Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neusci Biobehav Rev 1992;16:525-534.
29. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. New York, Academic Press, 1982.
30. Lindvall O, Björklund A: Dopamine and nor-epinephrine containing neuron systems: Their anatomy in the rat brain; in Emson PC (ed): Chemical Neuroanatomy. New York, Raven Press, 1983, pp 229-255.
31. Richelson E, Nelson A: Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. Pharmacol Exp Ther 1984;230:94-102.
32. Richelson E, Pfenning M: Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 1984;104:277-286.
33. Weller ME, Rose S, Jenner P, Morsden CD: In vitro characterization of dopamine receptor in the superior colliculus of the rat. Neuropharmacology 1987;26:347-354.
34. Fuller RW, Wong DT: Inhibition of serotonin reuptake. Fed Proc 1977;36:2154-2158.
35. Esposito E: An indirect action for fluoxetine on the dopamine neurotransmitter system. Trends Pharmacol Sci 1996;17:400-401.
36. Guan XM, McBride WJ: Serotonin microinjection into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull 1989;23:541-549.
37. Andersson JL, Nomikos GG, Marcus M, Hertel P, Mathe JM, Svensson TH: Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system. Naunyn Schmiedeberg's Arch Pharmacol 1995;253:374-385.
38. 3 receptors. J Neurosci 1998;8:6528-6538.
39. De Deurwaerdere P, Spampinato U: Role of serotonin2A and serotonin2B/2C receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. J Neurochem 1999;73:1033-1034.
40. Parsons LH, Jutice JB: Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 1993;606:195-199.
41. Serra G, Argiolas A, Klimek V, Fadda F, Gessa GL: Chronic treatment with antidepressant prevents the inhibitory effects of small doses of apomorphine on synthesis and motor activity. Life Sci 1979;25:415-420.
42. Akaike A, Sasa M, Takaori S: Microiontophoretic studies of the dopaminergic inhibition from the VTA to the NAcc neurons. J Pharmacol Exp Ther 1984;229:859-864.
43. Yim CY, Mogenson GJ: Responses of NAcc neurons to amygdala stimulation and its modification by dopamine. Brain Res 1982;239:401-415.
44. Yang CR, Mogenson GJ: Electrophysiological responses of neurons in the NAcc to hippocampal stimulation and the attenuation of the excitatory responses by the mesolimbic dopaminergic system. Brain Res 1984;324:69-84.
45. Beauregard M, Ferron A, Descarries L: Comparative analysis of the iontophoretically applied dopamine in different regions of the rat brain, with special reference to the cingulate cortex. Synapse 1991;9:27-34.
46. García-Sevilla JA, Prado D, Giralt T, Gumon J, Areso P: Alpha2-adrenoreceptor-mediated inhibition of platelet adenylate cyclase and induction of aggression in major depression. Arch Gen Psychiatry 1990;47:125-132.
47. 2-adrenoceptors. Naunyn Schmiedeberg's Arch Pharmacol 2001;363:66-77.
48. 3H]dopamine release from rat NAcc slices. Brain Res 1985;334:235-242.
49. Detke MJ, Rickels M, Lucki I: Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 1995;121:66-72.
50. Detke MJ, Johnson J, Lucki I: Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 1997;5:107-112.
51. Contreras CM, Rodríguez-Landa JF, Gutiérrez-García AG, Bernal-Morales B: The lowest effective dose of fluoxetine in the forced swim test significantly affects the firing rate of lateral septal nucleus neurons in the rat. J Psychopharmacol 2001;15:231-236.
52. Molina-Hernández M, Téllez-Alcántara NP: Antidepressant-like actions of pregnancy, and progesterone in Wistar rats forced to swim. Psychoneuroendocrinology 2001;26:479-491.
53. Contreras CM, Alcalá-Herrera V, Marván ML: Action of antidepressant on the lateral septal nuclei of the rat. Physiol Behav 1989;46:793-798.
54. Contreras CM, Marván ML, Alcalá-Herrera V, Guzmán-Sáenz MA: Chronic clomipramine increases firing rate in the lateral septal nuclei of the rat. Physiol Behav 1990;48:551-554.
55. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedeberg's Arch Pharmacol 1995;352:141-148.
56. Czachura JF, Rasmussen K: Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn Schmiedeberg's Arch Pharmacol 200;362:266-275.
57. Beasley CM, Bosomworth JC, Wernicke JF: Fluoxetine: Relationship among dose, response, adverse events, and plasma concentrations in the treatment of depression. Psychopharmacol Bull 1990;26:18-24.
58. Heimer L, Zahm DS, Churchill L, Kalivas PW, Wholtmann C: Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 1991;4:89-125.
59. Deutch AY, Cameron DS: Pharmacological characterization of dopamine systems in the NAcc core and shell. Neuroscience 1992;46:49-56.
60. Zahm DS, Brog JS: On the significance of sub-territories in the accumbens part of the rat ventral striatum. Neuroscience 1992;50:751-767.
61. Gal G, Joel D, Gusak O, Feldon J, Weiner I: The effects of electrolytic lesion to the shell subterritory of the NAcc on the delayed non-matching-to- sample and four-arm baited eight-arm radial-maze tasks. Behav Neurosci 1997;111:92-103.